Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 124
Genomics 98
Drug Discovery 70
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 58
Cardiovascular Drugs 56
Pharmaceuticals 53
Biopharmaceuticals 42
Biotechnology 39
Leukemia Drugs 35
Clinical Trials 33
Lymphoma Drugs 30
HIV/AIDS Drugs 27
Respiratory Drugs 26
Musculoskeletal Disorders Drugs 26
Enzymes 22
Oncology 22
Pulmonary Medicine 21
Allergy and Immunology 21
Pharmaceutical Manufacturing 21
Drug Delivery 19
Central Nervous System Drugs 17
Infusions and Injectables 17
Infectious Disease Testing 14
Vaccines 14
Gastrointestinal Drugs 12
Diagnostics 11
Hematological Drugs 11
Endocrine and Metabolic Disorders Drugs 10
Sexual and Reproductive Health Drugs 10
Healthcare Services 9
Hematology 9
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Women's Health 7
Breast Cancer Drugs 7
Hepatology 6
Lung Cancer Drugs 6
Stem Cells 6
Nanomedicine 6
Pediatrics 6
Company Reports 5
Colon Cancer Drugs 5
Needles and Syringes 5
Liver Cancer Drugs 4
Generic Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Analgesics 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Pharmacoeconomics 3
Ovarian Cancer Drugs 3
Dental 3
Optical 3
Anesthetic Drugs 3
Medical Devices 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
E-Healthcare 2
Prostate Cancer Drugs 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
Home Testing and Home Healthcare 2
In Vitro Diagnostics 2
Blood Banking 2
Over the Counter (OTC) Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Urological Disorders Drugs 2
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Cardiology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

1,022 Results (Page 43 of 52)
- Relevance
  Sort by

Tumor Infiltrating Lymphocytes Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

Germ Cell Tumor Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

Appendiceal Cancer Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

Cancer Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

 Report
July 2024
200 Pages
Global

From

€4230EUR$4,750USD£3,666GBP

Antibody Drug Conjugates Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Recombinant DNA Technology Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

Cancer Immunotherapy Market Report 2025

 Report
January 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

PD-1 and PD-L1 Inhibitors Market Report and Forecast 2025-2034

 Report
June 2025
400 Pages
Global

From

€4407EUR$4,949USD£3,820GBP

Anthracycline Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

Viral RNA Polymerase Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1113EUR$1,250USD£965GBP

Small Molecule API Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

Urothelial Cancer Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

Head and Neck Cancer Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

Solid Tumor Cancer Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,465GBP

Polycythemia Vera Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
99 Pages
Global

From

€3500EUR$4,210USD£3,140GBP

Africa Anti-Rheumatic Drugs Market - Forecasts from 2023 to 2028

 Report
February 2023
135 Pages
Africa

From

€2672EUR$3,000USD£2,315GBP

€3339EUR$3,750USD£2,894GBP

Antibody-drug Conjugates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
200 Pages
Global

From

€4230EUR$4,750USD£3,666GBP

Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1113EUR$1,250USD£965GBP

Immunotherapy Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4230EUR$4,750USD£3,666GBP

Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
249 Pages
Global

€4448EUR$4,995USD£3,855GBP

1,022 Results (Page 43 of 52)
- 1
- 41
- 42
- 43
- 44
- 45

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.